Zuranolone: The First Oral Treatment for Postpartum Depression
Dr. Marchand discusses the approval of zuranolone, how it differs from existing therapy for postpartum depression, and which patients stand to benefit.
DetailsDr. Marchand discusses the approval of zuranolone, how it differs from existing therapy for postpartum depression, and which patients stand to benefit.
DetailsEvery paper, abstract and presentation Dr. Marchand publishes is listed in his open research repository. Subscribe by RSS to be notified whenever new work is added.
Browse the repository All research (RSS)
Topic feeds: Peer-reviewed articles | Conference presentations